http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 http://www.tapanray.in/with-free-medicines-in-would-the-new-government-revisit-universal-health-coverage-soon/?utm_source=rss&utm_medium=rss&utm_campaign=with-free-medicines-in-would-the-new-government-revisit-universal-health-coverage-soon http://www.tapanray.in/with-free-medicines-in-would-the-new-government-revisit-universal-health-coverage-soon/#comments Mon, 02 Jun 2014 00:00:19 +0000 Tapan Ray http://www.tapanray.in/?p=5462 Continue reading →]]> http://www.tapanray.in/with-free-medicines-in-would-the-new-government-revisit-universal-health-coverage-soon/feed/ 0 http://www.tapanray.in/for-affordable-healthcare-synergize-resources-through-ppp-models/?utm_source=rss&utm_medium=rss&utm_campaign=for-affordable-healthcare-synergize-resources-through-ppp-models http://www.tapanray.in/for-affordable-healthcare-synergize-resources-through-ppp-models/#comments Mon, 24 Feb 2014 00:00:03 +0000 Tapan Ray http://www.tapanray.in/?p=4702 Continue reading →]]> http://www.tapanray.in/for-affordable-healthcare-synergize-resources-through-ppp-models/feed/ 0 http://www.tapanray.in/two-paintings-on-the-same-canvas-truth-about-drug-companies-and-protecting-access-to-medicines/?utm_source=rss&utm_medium=rss&utm_campaign=two-paintings-on-the-same-canvas-truth-about-drug-companies-and-protecting-access-to-medicines http://www.tapanray.in/two-paintings-on-the-same-canvas-truth-about-drug-companies-and-protecting-access-to-medicines/#comments Mon, 13 May 2013 00:00:29 +0000 Tapan Ray http://www.tapanray.in/?p=2280 Continue reading →]]> http://www.tapanray.in/two-paintings-on-the-same-canvas-truth-about-drug-companies-and-protecting-access-to-medicines/feed/ 0 http://www.tapanray.in/new-drug-prices-are-astronomicalunsustainable-and-immoral-anatomy-of-unique-protests/?utm_source=rss&utm_medium=rss&utm_campaign=new-drug-prices-are-astronomicalunsustainable-and-immoral-anatomy-of-unique-protests http://www.tapanray.in/new-drug-prices-are-astronomicalunsustainable-and-immoral-anatomy-of-unique-protests/#comments Mon, 06 May 2013 00:00:37 +0000 Tapan Ray http://www.tapanray.in/?p=2347 Continue reading →]]> http://www.tapanray.in/new-drug-prices-are-astronomicalunsustainable-and-immoral-anatomy-of-unique-protests/feed/ 0 http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/?utm_source=rss&utm_medium=rss&utm_campaign=a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/#comments Mon, 22 Apr 2013 00:00:26 +0000 Tapan Ray http://www.tapanray.in/?p=2193 Continue reading →]]> http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/feed/ 0 http://www.tapanray.in/does-the-landmark-glivec-judgment-discourage-innovation-in-india/?utm_source=rss&utm_medium=rss&utm_campaign=does-the-landmark-glivec-judgment-discourage-innovation-in-india http://www.tapanray.in/does-the-landmark-glivec-judgment-discourage-innovation-in-india/#comments Mon, 08 Apr 2013 00:00:19 +0000 Tapan Ray http://www.tapanray.in/?p=2150 Continue reading →]]> http://www.tapanray.in/does-the-landmark-glivec-judgment-discourage-innovation-in-india/feed/ 0 http://www.tapanray.in/the-rd-factor-one-of-the-great-myths-of-the-industry/?utm_source=rss&utm_medium=rss&utm_campaign=the-rd-factor-one-of-the-great-myths-of-the-industry http://www.tapanray.in/the-rd-factor-one-of-the-great-myths-of-the-industry/#comments Mon, 25 Mar 2013 00:00:56 +0000 Tapan Ray http://www.tapanray.in/?p=2085 Continue reading →]]> http://www.tapanray.in/the-rd-factor-one-of-the-great-myths-of-the-industry/feed/ 0 http://www.tapanray.in/new-patient-compensation-norms-on-clinical-trials-in-india-overdue-action-sharp-reaction-and-ethical-issues/?utm_source=rss&utm_medium=rss&utm_campaign=new-patient-compensation-norms-on-clinical-trials-in-india-overdue-action-sharp-reaction-and-ethical-issues http://www.tapanray.in/new-patient-compensation-norms-on-clinical-trials-in-india-overdue-action-sharp-reaction-and-ethical-issues/#comments Mon, 25 Feb 2013 00:00:18 +0000 Tapan Ray http://www.tapanray.in/?p=1996 Continue reading →]]> http://www.tapanray.in/new-patient-compensation-norms-on-clinical-trials-in-india-overdue-action-sharp-reaction-and-ethical-issues/feed/ 0 http://www.tapanray.in/revocation-and-denial-of-patents-on-patentability-ground-in-india-the-fallout-and-the-road-ahead/?utm_source=rss&utm_medium=rss&utm_campaign=revocation-and-denial-of-patents-on-patentability-ground-in-india-the-fallout-and-the-road-ahead http://www.tapanray.in/revocation-and-denial-of-patents-on-patentability-ground-in-india-the-fallout-and-the-road-ahead/#comments Mon, 03 Dec 2012 00:00:28 +0000 Tapan Ray http://tapanray.in/index.php/?p=1060 Continue reading →]]> http://www.tapanray.in/revocation-and-denial-of-patents-on-patentability-ground-in-india-the-fallout-and-the-road-ahead/feed/ 0 http://www.tapanray.in/robust-implementation-of-biosimilar-guidelines-could-help-india-earn-leadership-status-in-biosimilar-world/?utm_source=rss&utm_medium=rss&utm_campaign=robust-implementation-of-biosimilar-guidelines-could-help-india-earn-leadership-status-in-biosimilar-world http://www.tapanray.in/robust-implementation-of-biosimilar-guidelines-could-help-india-earn-leadership-status-in-biosimilar-world/#comments Mon, 05 Nov 2012 00:00:08 +0000 Tapan Ray http://tapanray.in/index.php/?p=1072 Continue reading →]]> http://www.tapanray.in/robust-implementation-of-biosimilar-guidelines-could-help-india-earn-leadership-status-in-biosimilar-world/feed/ 0